 |
 |
 |
 |
 |
 |
 |
 |
Rick Lathrop is a Professor in the School of Information and Computer Science at the University of California, Irvine. He holds a B.A. in Mathematics from Reed College, and a master's in Computer Science, the graduate degree of Electrical Engineer, and a Ph.D. in Artificial Intelligence from the Massachusetts Institute of Technology. His research interests are in artificial intelligence and computational biology. Dr. Lathrop has received Best Paper Awards for his work in computational biology. He is on the Editorial Boards of Molecular and Cellular Proteomics (2001--present) and IEEE Intelligent Systems (2002--present), and Chair of the National Institutes of Health grant review panel on BioData Management and Analysis (2003-present).
G. Wesley Hatfield, Ph.D.
Wes Hatfield is a Professor of Microbiology and Molecular Genetics in the College of Medicine at the University of California, Irvine. Dr. Hatfield holds a Ph.D. degree from Purdue University, and a B.A. degree from the University of California at Santa Barbara. His primary areas of scientific expertise include molecular biology, biochemistry, microbial physiology, functional genomics, and bioinformatics. His recent academic interests include the application and development of genomic and bioinformatics methods to elucidate the effects of chromosome structure and DNA topology on gene expression. He has received national recognition for his scientific contributions.
James Larrick, M.D., Ph.D.
Jim Larrick enjoys an international reputation in biotechnology (cytokines, therapeutic antibodies, molecular biology, pharmaceutical drug development) having written or co-authored eight books, over 220 papers/chapters and fifteen patents. He serves on the editorial board of six journals. Dr. Larrick received his M.D. and Ph.D. degrees from Duke University School of Medicine, Durham, NC. After house staff training in the Department of Medicine at Stanford University School of Medicine, he completed a post-doctoral fellowship in the Stanford Cancer Biology Research Labs with Professor Henry S. Kaplan. Dr. Larrick has also founded more than a dozen biopharmaceutical companies.
Michael Zuker, Ph.D.
Michael Zuker is a Professor of Mathematical Sciences at Rensselaer Polytechnic Institute's School of Science. He has a cross appointment in the Biology Department. Professor Zuker is interested in Bioinformatics, specifically in algorithms for nucleic acid and protein sequence analysis. He is best known for his work on algorithms for predicting RNA and DNA secondary structure and his mfold program for RNA folding.
Herbert L. Heyneker, Ph.D.
Herb Heyneker was formerly Chief Technical Officer of Eos Biotechnology, a genomics company he co-founded in 1996. Eos was acquired by Protein Design Labs in April 2003. He was involved in founding several life science companies including, GlycoGen and GenPharm International. Previously, he served as Vice President, Research at Genencor International and was a Visiting Scholar in the Department of Genetics at Stanford University's Medical School. He started his career as a post-doc in Herb Boyer's lab at UCSF from 1975 till 1977, and was a Senior Scientist at Genentech for the next seven years where he published pioneering papers on the cloning and microbial expression of somatostatin, human insulin and human growth hormone. He is an inventor on over 30 issued patents.
Stefan Lutz, Ph.D.
is an Assistant Professor of Biomolecular Chemistry in the Department of Chemistry at Emory University, Atlanta, GA. He received his Ph.D. in Chemistry from the University of Florida (1999), an MSc in Biotechnology from the University of Teesside, UK (1995) and a BSc in Chemistry from the Zurich University of Applied Sciences, Switzerland (1992). His research is focused on tailoring the functional properties of enzymes by protein engineering and directed evolution to find novel and improved biocatylysts for therapeutic and industrial applications.